Internal Medicine Doctors in Sherman, CT Accepting Medicare
1 Internal Medicine doctors found. Showing 1 - 1
 Mark J Kunkel, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 23 Deer Run Trl, Sherman, CT 06784 Phone: 860-355-0403 |
News Archive
Amgen to present Phase 2 study data of AMG 479 in metastatic pancreatic cancer at 2010 ASCO
Amgen today announced results from a small, randomized, placebo-controlled Phase 2 study indicating that adding AMG 479 to gemcitabine improved overall survival at six months (primary endpoint) and progression-free survival in patients with metastatic pancreatic cancer. The study, which also included a separate arm of conatumumab plus gemcitabine, is being presented in a Poster Discussion at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting.
New WHO policy recommendation warns against use of blood tests for active TB
A new policy recommendation released on 20 July by the World Health Organization (WHO) warns against the use of serological (blood) tests to diagnose active tuberculosis.
Health Canada recommends new pneumococcal vaccine for young children
In December, 2009, Health Canada approved a new vaccine for children aged six weeks through five years to prevent infections caused by the bacteria called pneumococcus or Streptococcus.
Cancer Research UK launches campaign to protect children from tobacco
Through 'Out of Sight, Out of Mind', the charity is aiming to protect the next generation from this deadly addiction and is calling on people across the UK to sign up to a petition to support its aims. Research shows that the younger people start to smoke, the harder they find it to quit and to stay quit for good, a worrying statistic as over 80 per cent of smokers start before the age of 19.
Genzyme announces reopening of enrollment in its Pompe disease ATAP program
Genzyme Corporation announced today that it will reopen enrollment in the Alglucosidase Alfa Temporary Access Program (ATAP), a program which provides access to treatment for severely affected adults with Pompe disease prior to commercial approval of Lumizyme™ (alglucosidase alfa). Genzyme and the FDA have also agreed on a path toward approval of Lumizyme.
› Verified 7 days ago